Health Decision Technologies, LLC

Health Decision Technologies (HDT) is a boutique digital health firm that develops clinically validated mobile health (mHealth) interventions and AI-driven clinical decision support tools. The company is known for its evidence-based approach, often partnering with academic institutions like the University of Virginia and receiving funding from the NIH to address complex health behaviors and chronic disease management. HDT's current focus includes the development of 'Project BRIDGE,' a deterministic conversational control system designed to govern AI in regulated, high-risk clinical environments. Unlike standard chatbots, BRIDGE optimizes for instructional integrity and clinical grounding, ensuring that AI interactions remain safe and compliant within healthcare workflows.